Breathe Well Live Well
|
Valley Children's recognized for asthma treatment, maternal-fetal care
Fresno Business Journal Two national healthcare organizations have recognized Valley Children's Hospital for performing exceptionally well on evidence-based care processes for the treatment of children's asthma and maternal-fetal care. Due to its extraordinary performance in … |
View full post on asthma – Google News
I4U News |
Everything to Know About the Flu – Season, Symptoms, Prevention, Treatment
I4U News Complications from flu in this case could be pneumonia, bronchitis, sinus, ear infections, severe asthma, and triggered heart failure among others. These situations require hospitalizations in emergency ward, and treatment may last for a couple of weeks. Biography – Centers for Disease Control and Prevention Madagascar (cVDPV) – Global Polio Eradication Initiative Disease Outbreak Control Division | Dengue Outbreak 2015 – Hawaii Department … |
View full post on asthma – Google News
| Related Articles |
A short review on structure and role of cyclic-3′,5′-adenosine monophosphate-specific phosphodiesterase 4 as a treatment tool.
J Res Pharm Pract. 2015 Oct-Dec;4(4):175-181
Authors: Eskandari N, Mirmosayyeb O, Bordbari G, Bastan R, Yousefi Z, Andalib A
Abstract
Cyclic nucleotide phosphodiesterases (PDEs) are known as a super-family of enzymes which catalyze the metabolism of the intracellular cyclic nucleotides, cyclic-3′,5′-adenosine monophosphate (cAMP), and cyclic-3′,5′-guanosine monophosphate that are expressed in a variety of cell types that can exert various functions based on their cells distribution. The PDE4 family has been the focus of vast research efforts over recent years because this family is considered as a prime target for therapeutic intervention in a number of inflammatory diseases such as asthma, chronic obstructive pulmonary disease, and rheumatoid arthritis, and it should be used and researched by pharmacists. This is because the major isoform of PDE that regulates inflammatory cell activity is the cAMP-specific PDE, PDE4. This review discusses the relationship between PDE4 and its inhibitor drugs based on structures, cells distribution, and pharmacological properties of PDE4 which can be informative for all pharmacy specialists.
PMID: 26645022 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
|
Ask the Expert: Bronchoscopic treatment for asthma
KUTV 2News Dr. Danai Khemasuwan, an interventional pulmonologist from Intermountain Medical Center, met with 2News to go over how bronchoscopic treatment for asthma works. Bronchial thermoplasty is relatively new bronchoscopic treatment for refractory, steroid … |
View full post on asthma – Google News
|
Reslizumab deemed safe, efficacious for treatment of asthma
Healio In a recent extension study, researchers found reslizumab was safe, efficacious and improved Asthma Quality of Life scores for up to 2 years after beginning treatment, according to data recently presented at the American College of Allergy, Asthma and … |
View full post on asthma – Google News
|
EMS assessment and treatment of asthma: 5 things to know
EMS1.com Asthma is a chronic disease that affects 24 million people in the United States and causes 5,000 to 6,000 deaths each year [1,2]. Prompt recognition and treatment of asthma, a leading cause of respiratory compromise, by EMS providers can quickly … |
View full post on asthma – Google News
|
Asthma health news roundup 2015: Asthma attack and treatment
Bel Marra Health Asthma is a condition that affects our airways and breathing. Although manageable, many asthmatics do not have their condition under control, which can lead to further health complications and a worsened quality of life. There have been many links and … |
View full post on asthma – Google News
Local 10 |
New treatment option for people with asthma
Local 10 An estimated 25 million Americans struggle with asthma, a chronic disease involving the airways in the lungs. Show Transcript Hide Transcript. DEFINITELY A LOT OF RAIN. IN THE ATMOSPHERE. Calvin: AN ESTIMATED 25 MILLION AMERICANS … |
View full post on asthma – Google News
|
Researchers test new asthma treatment in Amarillo
Amarillo.com Amarillo was chosen as one of 600 test sites worldwide for a new clinical trial for asthma, and researchers are looking for local participants. On Monday, PharmaTex Research, a provider of clinical trial services in the region, announced the beginning … |
View full post on asthma – Google News
|
Ajanta Pharma launches generic asthma treatment tablets in US
Economic Times NEW DELHI: Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast … Ajanta Pharma launches generic asthma treatment tablets Ajanta Pharma launches anti-asthma tablets in US |
View full post on asthma – Google News